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Background.– Fatigue is a common and disabling symptom in multiple sclerosis.
The objective of this work was to study the impact of a therapeutic education
program on fatigue management and its effect on quality of life.
Methods.– One-day seminar, divided into several workshops on the topic of
fatigue. Evaluation at 3 months of the impact on quality of life. Inclusion crite-
ria: people with multiple sclerosis, evolving for more than a year and less
than 10 years, complaining of fatigue as most incapacitating symptom with a
maximum EDSS score of 3.5.
Results.– Sixteen patients have benefited from this program, at 3 months there
was a non significant decrease in the score of the EMIF scale, and an improve-
ment of quality of life on the SF36 scale, with a significant gain on the item
vitality.
Discussion.– This work highlights the importance of therapeutic education pro-
gram in the field of fatigue and more broadly on disability in multiple sclerosis.
Patients were able to develop coping strategies in everyday life, allowing them
to limit the consequences of neurological impairment.
Conclusion.– Therapeutic education can improve the quality of life of patients
suffering from multiple sclerosis especially in the field of fatigue management.
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Objective.– Fampyra effect on spasticity and fatigue in multiple sclerosis.
Methods.– This is a retrospective study of prospectively collected data on patients
with multiple sclerosis. Effectiveness was tracked after 14 days of treatment
using the T25FWT as an objective measure of walking speed. Fatigue was mea-
sured with the EMIF-SEP questionnaire and spasticity with a validated 0–10
Numerical Rating Scale (NRS).
Results.– Hundred and forty-six patients were recruited between April 2013 and
October 2013. Hundred and thirty-five patients (age: 54 ± 18, 6; EDSS median:
6) were evaluated: T25FWT decreased significantly (P < 0.0001). EMIF-SEP
overall score decreased significantly (P < 0.0001) and all dimensions of it
(P < 0.0001). NRS score decreased significantly (–28%; P < 0.0001).
Conclusion.– Dalfampridine has a positive effect on walking ability [1], spas-
ticity [1] and fatigue.
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Objective.– The aim of this study is to measure the impact of multiple sclerosis
(MS) on energy expenditure (EE) during daily tasks in a kitchen.
Methods.– Nine SEP patients (SEPG) and nine healthy subjects (CG) have par-
ticipated in this study. The EE (kJ.kg−1) has been determined by an indirect
calorimetry analysis (K4b2) during three pathways each comprising: carrying
loads, opening/closing of drawers and round trips in the kitchen.
Results.– The average EE values by pathway was 5.15 ± 1.5 (P1), 4.32 ± 1.5
(P2) and 4.23 ± 1.2 (P3) kJ.kg−1 for SEPG and 4.58 ± 2.6 (P1), 4.45 ± 2.5 (P2)
and 4.38 ± 2.7 (P3) kJ.kg−1 for CG. The two-way Anova for repeated measures
(SEPG-CG vs P1-P2-P3) showed a pathway effect (F[2,16] = 4.6, P = 0.03) but
no group effect (F[1,8] = 0.02, P > 0.05). A significant decrease between P1 and
P3 was observed in SEPG (P = 0.04) but not for CG (P > 0.05).
Discussion.– The higher energy cost at the beginning than at the end of the
protocol for GSEP seems to be due to the habituation of the tasks. The gesture
economy in GSEP could be achieved through learning.
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If, as described by Naiditch, a network consists of a set of actors staging pro-
cess for which they are accountable, creating health networks, including those
dedicated to multiple sclerosis, enrolled in health policy in France. Ordinances
of 24 April 1996, called Ordinances Juppé, aimed to mobilize the health, social
and other resources around the needs of the territory, to provide better refer-
rals, promote coordination and continuity of care, promote the quality of local
health care delivery. Thus, the creation of networks, more or less experimental,
coming “from above” to get a force of law. Thereafter, various methods have
framed the creation of networks: the Improvement Fund to Quality Care in the
City (12 November 1999) and the National Endowment for the Development
of Networks (21 December 2001) and the base of Intervention for Quality and
Care Coordination (1 July 2007).
What are the current networks’ successes or gaps? If they were created on a close
model, what are the specificity of MS networks covering the national territory,
what are their differences and their possible links? What is the future of networks
and of which ones?
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